Brass Tax Wealth Management, Inc Regeneron Pharmaceuticals, Inc. Transaction History
Brass Tax Wealth Management, Inc
- $252 Million
- Q3 2024
A detailed history of Brass Tax Wealth Management, Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Brass Tax Wealth Management, Inc holds 353 shares of REGN stock, worth $261,223. This represents 0.15% of its overall portfolio holdings.
Number of Shares
353
Previous 353
-0.0%
Holding current value
$261,223
Previous $371 Million
99.9%
% of portfolio
0.15%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,535Shares Held
83.8MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.25 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.54 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.63 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.18 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $79.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...